Searched for
LUPIN LIMITED GROUP
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...- Stocks in news: IndiGo, Sammaan Capital, Bharti Airtel, GRSE, CoforgeMarkets experienced a sharp sell-off on Monday's monthly expiry day, with the Nifty closing near 22,331. Key companies like IndiGo, Bharti ...
- Stocks in news: Fractal Analytics, RIL, Cochin Shipyard, Trent, BritanniaMarkets saw volatility but recovered modestly on Monday, with analysts maintaining a cautious outlook. Several stocks like Fractal Analytic...
- Lupin enters pact with Medis to distribute orphan drug in EuropeNDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following vol...
- Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...
- Lupin gets USFDA nod to market skin ointmentThe product will be manufactured at the company's Pithampur, Unit 3 facility, Lupin said in a filing to the BSE. The approval by the United...
- Lupin looks to sell Japanese arm Kyowa for $600 millionKyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupin’s consolidated profit. "...
- Lupin appoints Sreeji Gopinathan as its CIO"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience," Lupin said in a statement.
- Waiting for election to be over and hoping for steeper cuts in interest rates: Dipan MehtaThe recent lawsuit on Indian generic manufacturers brings an element of uncertainty to pharma, says Mehta.
- Lupin gets more time from govt to complete project in Indore SEZThe company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations metered dose inhalers and dry powder inh...
- Stocks in the news: Lupin, Indiabulls Housing, Hotel Leelaventure, UltraTech Cement and Tata PowerTataPower has signed an agreement to sell its 32-mw operating wind assets.
- Market outlook: Nifty50 likely to stay tentative, see consolidationChances are we will see a relatively stable opening for the market on Friday.
- Tata Motors lone indian among top global R&D spendersThe Government of India’s Economic Survey 2017-18 has called for doubling of national expenditures on R&D.
- Tata Motors lone Indian name among top 100 global R&D spendersAs per Bloomberg data, Tata Motors (standalone) figures at the 99th position globally, but on including JLR, its rank rises to an impressiv...
- 12 stocks that can still give you gains in a weak marketAnalysts say the market is likely to turn volatile during the coming week.
- JSW Group HR head Yugesh Goutam quits to join Lupin as President-HRGoutam comes to Lupin from JSW Group where he was Group President – Human Resources with responsibility for HR function across all their bu...
- Lupin to challenge Pregabalin ruling by US courtLupin Limited says it will challenge a US court order that prevents it from selling a low-cost generic version of Pfizer's nerve pain drug ...
- Lupin gets USFDA approval for hypertension drugDrug-maker Lupin said it has received approval from the US health regulator to market Amlodipine Benazepril capsules in the American market.
- Apollo, Lupin unveil country's first disease management planApollo Hospitals Group has joined hands with Lupin Limited to create the first Disease Management Programme (DMP) for Bronchial Asthma and ...
- Lupin appoints Swaminathan as PresidentPharma company Lupin Limited appoints Ramesh Swaminathan as its President for finance and planning.
Load More
